BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33209627)

  • 1. A narrative review of lung cancer cytology in the times of coronavirus: what physicians should know.
    Pisapia P; Malapelle U; Salatiello M; Rosell R; Troncone G
    Transl Lung Cancer Res; 2020 Oct; 9(5):2074-2081. PubMed ID: 33209627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juggling the COVID-19 pandemic: A cytopathology point of view.
    Iaccarino A; Pisapia P; Vigliar E; Vielh P; Troncone G
    Cytopathology; 2021 May; 32(3):299-303. PubMed ID: 33145830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the practice of molecular cytopathology in response to the COVID pandemic.
    Troncone G
    Cytopathology; 2023 Sep; 34(5):417-418. PubMed ID: 37291942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventional cytopathology and cancer in Peru: how to act during COVID-19?
    Abad-Licham M; Astigueta J; Fernández CL; Torres HC; Torres GM; Figueroa E; Bardales R
    Ecancermedicalscience; 2020; 14():1152. PubMed ID: 33574897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indian Academy of Cytologists National Guidelines for Cytopathology Laboratories for Handling Suspected and Positive COVID-19 (SARS-CoV-2) Patient Samples.
    Srinivasan R; Gupta P; Rekhi B; Deb P; Nijhawan VS; Prasoon D; Iyer V; Mathur S; Gupta N; Kamal M; Goel MM; Chakrabarti I; Jena M; Rao RN; Rajwanshi A; Raju S; Verma S; Pinto R
    J Cytol; 2020; 37(2):67-71. PubMed ID: 32606493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and Serological Tests for COVID-19 a Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics.
    Kubina R; Dziedzic A
    Diagnostics (Basel); 2020 Jun; 10(6):. PubMed ID: 32604919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018.
    Pisapia P; Bellevicine C; Malapelle U; De Luca C; Vigliar E; Troncone G
    Cancer Cytopathol; 2019 Jun; 127(6):350-357. PubMed ID: 31135103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The COVID-19 pandemic has impeded cytopathology practices and hindered cancer screening and management.
    Huang CY; Chen CC
    Cytopathology; 2023 Sep; 34(5):406-416. PubMed ID: 37332230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytologic rapid on-site evaluation of transthoracic computed tomography-guided lung needle biopsies: who should perform ROSE? A cross-institutional analysis of procedural and diagnostic outcomes.
    Marotti JD; Rao KP; Brister KJ; Gutmann EJ; Tsapakos MJ; Sheiman R; Wang HH; VanderLaan PA
    J Am Soc Cytopathol; 2015; 4(3):160-169. PubMed ID: 31051697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic.
    Pisapia P; Pepe F; Gristina V; La Mantia M; Francomano V; Russo G; Iaccarino A; Galvano A
    Mediastinum; 2021; 5():27. PubMed ID: 35118332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential Role of Super Spread Events in SARS-COV-2 Pandemic; a Narrative Review.
    Kyriakopoulos AM; Papaefthymiou A; Georgilas N; Doulberis M; Kountouras J
    Arch Acad Emerg Med; 2020; 8(1):e74. PubMed ID: 33134970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study of severe acute respiratory syndrome-associated coronavirus in tissue sections of patients.
    Hsiao CH; Chang MF; Hsueh PR; Su IJ
    J Formos Med Assoc; 2005 Mar; 104(3):150-6. PubMed ID: 15818427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convalescent Blood Products in COVID-19: A Narrative Review.
    Chua Vi Long K; Sayed A; Karki P; Acharya Y
    Ther Adv Infect Dis; 2020; 7():2049936120960646. PubMed ID: 33014364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus Disease 2019: Latest Data on Neuroinvasive Potential.
    Haddadi K; Asadian L
    Iran J Med Sci; 2020 Sep; 45(5):325-332. PubMed ID: 33060875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the treatment of novel coronavirus disease (COVID-19) with Western medicine and traditional Chinese medicine: a narrative review.
    Al-Romaima A; Liao Y; Feng J; Qin X; Qin G
    J Thorac Dis; 2020 Oct; 12(10):6054-6069. PubMed ID: 33209439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of guidelines for respiratory cytology by the Papanicolaou Society of Cytopathology.
    Moreira AL
    Diagn Cytopathol; 2020 Oct; 48(10):867-869. PubMed ID: 32359109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision cytopathology: expanding opportunities for biomarker testing in cytopathology.
    Sanchez A; Bocklage T
    J Am Soc Cytopathol; 2019; 8(2):95-115. PubMed ID: 31287426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS).
    Tse GM; To KF; Chan PK; Lo AW; Ng KC; Wu A; Lee N; Wong HC; Mak SM; Chan KF; Hui DS; Sung JJ; Ng HK
    J Clin Pathol; 2004 Mar; 57(3):260-5. PubMed ID: 14990596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of cytopathology practice in Korea: impact of the coronavirus pandemic on cytopathology practice.
    Hong SA; Jung H; Kim SS; Jin MS; Pyo JS; Jeong JY; Choi Y; Gong G; Chong Y
    J Pathol Transl Med; 2022 Nov; 56(6):361-369. PubMed ID: 36288740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The practice of cytopathology during the era of COVID-19: challenges and changes.
    Baskota SU; Chandra A; Cross P
    Diagn Histopathol (Oxf); 2021 Mar; 27(3):116-122. PubMed ID: 33072189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.